BriaCell Therapeutics Corp(NASDAQ:BCTX) 
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing approaches for the management of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The ...
Website: http://www.briacell.com
Founded: 2006
CEO: Bill Williams
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 35.00
H 39.40
L 33.40
C 39.40
V 84,909
10EMA 39.40
20EMA 39.40
60EMA 39.40
120EMA 39.40
250EMA 39.40